Paper Details

  1. Home
  2. Paper Details

Combination therapy (interferon alfa and ribavirin) in the treatment of chronic hepatitis C: a rapid and systematic review.

Author: HewitsonP, ShepherdJ, WaughN

Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

This study compares the effectiveness of interferon alfa alone versus interferon alfa combined with ribavirin in treating chronic hepatitis C. While interferon alfa was the standard treatment, it only cured a small percentage of patients. The study aims to evaluate the added benefit of combining interferon with ribavirin, building upon previous research on this combination therapy.
Paper Details　
Original Abstract of the Article :
Hepatitis C is a viral disease of the liver, which frequently causes few or no symptoms at first infection but has a high probability of becoming an insidious chronic disease. Treatment has traditionally been with interferon alfa but only a small proportion of patients have been cured by this method...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/11134916

データ提供：米国国立医学図書館（NLM）

Combination Therapy: A New Era in Hepatitis C Treatment

Hepatitis C, a viral infection of the liver, can cause serious complications, including cirrhosis and liver cancer. This study reviews the benefits of combination therapy, using both interferon alfa and ribavirin, for the treatment of chronic hepatitis C. The researchers analyzed the available evidence, comparing combination therapy to interferon alfa monotherapy. Their findings suggest that combination therapy significantly improves the chances of cure compared to monotherapy. This research highlights the importance of combination therapy in the management of chronic hepatitis C, offering a more effective approach to treating this debilitating disease.

Improving Treatment Outcomes: The Power of Combination Therapy

The study's results highlight the significant advantage of combination therapy in treating chronic hepatitis C. The findings suggest that combining interferon alfa with ribavirin leads to higher cure rates compared to using interferon alfa alone. This research emphasizes the importance of exploring combination therapies to optimize treatment outcomes and improve patient well-being.

Navigating the Complexities of Hepatitis C Treatment

Hepatitis C treatment is a complex process that requires careful consideration of individual patient factors. This study underscores the importance of exploring different treatment strategies and adapting them to meet the needs of each patient. By understanding the benefits and limitations of various treatment options, we can work towards achieving better outcomes for individuals living with chronic hepatitis C.

Dr.Camel's Conclusion

Like a camel traversing a challenging landscape, treating chronic hepatitis C requires a strategic approach. This research highlights the importance of combination therapy, offering a more effective way to combat this debilitating disease and improve patient outcomes.

Date :
  1. Date Completed 2001-01-25
  2. Date Revised 2018-11-30
Further Info :

Pubmed ID

11134916

DOI: Digital Object Identifier

11134916

Related Literature

Article Analysis
・Effective treatment of hepatitis c
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.